Cite
HARVARD Citation
Choueiri, T. et al. (n.d.). 4LBA Cabozantinib versus everolimus in patients with advanced renal cell carcinoma: Results of the randomized phase 3 METEOR trial. European journal of cancer. pp. S708-S709. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Choueiri, T. et al. (n.d.). 4LBA Cabozantinib versus everolimus in patients with advanced renal cell carcinoma: Results of the randomized phase 3 METEOR trial. European journal of cancer. pp. S708-S709. [Online].